Induction of the Cyclin-dependent Kinase Inhibitor p21 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells
Open Access
- 1 April 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (15) , 10050-10057
- https://doi.org/10.1074/jbc.272.15.10050
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Nitric Oxide Induces Upregulation of Fas and Apoptosis in Vascular Smooth MuscleHypertension, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Nitric oxide inhibition of endothelial cell mitogenesis and proliferation*Surgery, 1995
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Pharmacology of smooth muscle cell replication.Hypertension, 1992
- Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.The Journal of Experimental Medicine, 1991
- Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALBc 3T3 fibroblasts by a cyclic GMP-independent mechanismBiochemical and Biophysical Research Communications, 1990